Generic Name: omega-3-carboxylic acids
Date of Approval: May 5, 2014
Treatment for: Hypertriglyceridemia
Medically reviewed by Drugs.com. Last updated on May 28, 2020.
The Epanova brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
FDA Approves Epanova
The United States Food and Drug Administration (FDA) has approved AstraZeneca’s Epanova (omega-3-carboxylic acids) in conjunction with diet to treat severe hypertriglyceridemia in adults. Hypertriglyceridemia condition characterized by high levels of triglycerides in the blood, and while an essential energy source for the body, high triglyceride levels can lead to serious health complications. Hypertriglyceridemia is considered severe when triglyceride levels are greater than or equal to 500 mg/dL.
Epanova is the first FDA approved prescription omega-3 in free fatty acid form. It is derived from fish oil and consists of an ultra-pure mixture of the free fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Similar prescription drugs used in the treatment of hypertriglyceridemia include Lovaza (omega-3-acid ethyl esters) and Vascepa (icosapent ethyl). Generic versions of Lovaza were approved in April 2013.
The FDA approval was based on data from a that included positive results from the Phase III EVOLVE (EpanoVa fOr Lowering Very High triglyceridEs) trial. AstraZeneca is continuing to evaluate the clinical profile of Epanova through a large-scale cardiovascular outcomes trial, STRENGTH (STatin Residual risk reduction with EpaNova in hiGh cardiovascular risk paTients with Hypertriglyceridemia) in combination with statin therapy. The company's statin product Crestor (rosuvastatin) holds a large market share and may be developed further as a fixed dose combination with Epanova.
The dosage of Epanova is 2 grams (2 capsules) or 4 grams (4 capsules), making it the first prescription omega-3 to have a dosing option as few as two capsules once a day, with or without food.
Epanova Patient Information
Read this Patient Information before you receive this medicine and each time you receive treatment. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
What is Epanova?
Epanova is a prescription medicine used along with a low fat and low cholesterol diet to lower very high triglyceride (fat) levels in adults.
- It is not known if it changes your risk of having inflammation of your pancreas (pancreatitis).
- It is not known if it prevents you from having a heart attack or stroke.
- It is not known if it is safe and effective in children.
Who should not take Epanova?
You should not take this medicine if you are allergic to omega-3-carboxylic acids or any of the other ingredients.
Before taking Epanova, tell your doctor about all your medical conditions, including if you:
- have diabetes
- have a low thyroid problem (hypothyroidism)
- have a liver problem
- have a pancreas problem
- are allergic to fish or shellfish
- are pregnant or plan to become pregnant, as it is not known if Epanova will harm your unborn baby
- are breastfeeding or plan to breastfeed, as Epanova can pass into your breast milk.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How should I take Epanova?
The usual dosage is 2 grams (2 capsules) or 4 grams (4 capsules) once daily without regard to meals.
You should take the exact dose your doctor prescribes.
Epanova side effects
Epanova may cause serious side effects, including:
- increases in the results of blood tests used to check your liver function (ALT and AST) and your bad cholesterol levels (LDL-C)
- possible allergic reactions if you are also allergic to fish or shellfish
The most common side effects include:
- upset stomach
- abdominal pain or discomfort
This is not a complete list of possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Storage and Handling
Epanova is a red/brown, soft gelatin capsule with imprint OME1.
- Store Epanova at room temperature between 68°F to 77°F (20°C to 25°C).
- Do not freeze.
- Keep all medicines out of the reach of children.
General information about the safe and effective use of Epanova
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your pharmacist or doctor for information that is written for health professionals. Do not use this medicine for a condition for which it was not prescribed. Do not give it to other people, even if they have the same symptoms that you have. It may harm them.
Active Ingredient: omega-3-carboxylic acids
Inactive Ingredients: α-tocopherol (in a carrier of vegetable oil), gelatin, glycerol, sorbitol, and purified water (components of the capsule shell). Coating and ink components to the capsules also contain ethyl acrylate and methyl methacrylate copolymer dispersion, talc, titanium dioxide, iron oxide red, polysorbate 80, and carboxymethylcellulose sodium (coating components), pharmaceutical glaze, titanium dioxide, n-butyl alcohol, propylene glycol and isopropanol (ink components)
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
The main differences between Lovaza and Vascepa are their FDA approved uses, dose, side effects and price. Both Lovaza and Vascepa are used to lower high triglycerides; however, Vascepa is also approved to be used with a statin to lower the chance of a heart attack or stroke. Read more
More about Epanova (omega-3 polyunsaturated fatty acids)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Drug class: nutraceutical products
- FDA Approval History